Elite Pharmaceuticals Inc (ELTP) Stock Analysis
Verdict: WATCH (do not buy)
Rapid revenue growth and cheap TTM valuation (P/E 5.2x) are eclipsed by severe downward momentum near 52W lows ($0.251).
Investment score: 45/100
Analysis as of
Is Elite Pharmaceuticals Inc stock worth reviewing? AI model thesis
The model score of 45/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment.
7-factor investment score
- Valuation: 65/100 (weight 20%)
- Financial Health: 75/100 (weight 15%)
- Technical Momentum: 20/100 (weight 15%)
- Earnings Quality: 40/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 35/100 (weight 15%)
Elite Pharmaceuticals Inc opportunities and risks
What speaks for ELTP
- Low valuation multiple relative to generic pharma peers
What speaks against ELTP
- Severe technical breakdown toward 52-week lows
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ELTP | 5.2x | 2.0x | 5.5x | 43.2% | 40.2% | 6.3% |
| PLTH.CN | n/a | 0.5x | n/a | 41.0% | -66.8% | -19.4% |
| FULC | n/a | 0.0x | n/a | 0.0% | 0.0% | -22.5% |
| TTRX | n/a | 0.0x | n/a | 0.0% | 0.0% | -1.5% |
| PLTH.CN | n/a | 0.5x | n/a | 41.0% | -66.8% | -19.4% |
| NMRA | n/a | 0.0x | n/a | 0.0% | 0.0% | -74.4% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -19.4% |
Frequently asked questions about Elite Pharmaceuticals Inc (ELTP)
Is ELTP stock a good investment?
The cached TradeMates AI model rates Elite Pharmaceuticals Inc as WATCH (do not buy) with an investment score of 45/100. The model score of 45/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment. This is algorithmic model output, not personal investment advice.
Is ELTP stock a buy?
The TradeMates model verdict for ELTP is WATCH (do not buy) with an investment score of 45/100. Treat this as a model signal to review, not a personal buy recommendation.